ARCHIVES

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

This article is from The Cancer Letter archive.

Vol. 23 No. 14 | April 11, 1997

Download PDF Visit The Full Archive

Related Articles

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

With NIH “Accountability” As Background, Advocates Support Budget Increases.

March 30, 2001

CLF Makes Appointments To Board; Stovall Wins Award.

April 20, 2001

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998